HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.

AbstractOBJECTIVE:
To compare the efficacy and safety of controlled release oxycodone given every 12 h around the clock with immediate release oxycodone-acetaminophen (APAP) given 4 times daily for osteoarthritis (OA) pain.
METHODS:
Adults (n=167) with moderate to severe OA pain despite regular use of nonsteroidal antiinflammatory drugs (NSAID) entered open label titration for 30 days with immediate release oxycodone qid; 107 qualified for randomization to double blind, parallel group treatment for 30 days with placebo, controlled release oxycodone, or immediate release oxycodone-APAP.
RESULTS:
Following titration with immediate release oxycodone, mean (SE) pain intensity (0, none to 3, severe) decreased from 2.44 (0.04) to 1.38 (0.05) (p=0.0001), and quality of sleep (1, very poor; 5, excellent) improved from 2.58 (0.08) to 3.57 (0.07) (p=0.0001). Mean dose was about 40 mg/day. Pain intensity and quality of sleep were significantly improved in both active groups compared with the placebo group (p< or =0.05) during the double blind trial. Pain intensity and sleep scores were comparable in both active groups during double blind treatment. Nausea (p=0.03) and dry mouth (p=0.09) were less common with controlled release oxycodone than immediate release oxycodone-APAP.
CONCLUSION:
Controlled release oxycodone q12h and immediate release oxycodone-APAP qid, added to NSAID, were superior to placebo for reducing OA pain and improving quality of sleep. The active treatments provided comparable pain control and sleep quality. Controlled release oxycodone was associated with a lower incidence of some side effects.
AuthorsJ R Caldwell, M E Hale, R E Boyd, J M Hague, T Iwan, M Shi, P G Lacouture
JournalThe Journal of rheumatology (J Rheumatol) Vol. 26 Issue 4 Pg. 862-9 (Apr 1999) ISSN: 0315-162X [Print] Canada
PMID10229408 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Anti-Inflammatory Agents, Non-Steroidal
  • Delayed-Action Preparations
  • Acetaminophen
  • Oxycodone
Topics
  • Acetaminophen (therapeutic use)
  • Adult
  • Aged
  • Aged, 80 and over
  • Analgesics, Non-Narcotic (therapeutic use)
  • Analgesics, Opioid (administration & dosage, therapeutic use)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Arthrography
  • Delayed-Action Preparations
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Humans
  • Joints (pathology)
  • Male
  • Middle Aged
  • Osteoarthritis (diagnostic imaging, drug therapy, physiopathology)
  • Oxycodone (administration & dosage, therapeutic use)
  • Pain (drug therapy)
  • Pain Measurement
  • Quality of Life
  • Sleep
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: